Cargando…

Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial

Detalles Bibliográficos
Autores principales:	Cohen, Ricardo V., Petry, Tarissa Beatrice Zanata, Miras, Alexander Dimitri, Aboud, Cristina Mamédio, Johnson, Brett, dos Santos, Tiago Mendonça, le Roux, Carel W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2021
Materias:	e-Letters – Observations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740946/ https://www.ncbi.nlm.nih.gov/pubmed/34362818 http://dx.doi.org/10.2337/dc21-1192

Ejemplares similares

Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial
por: Cohen, Ricardo Vitor, et al.
Publicado: (2017)

Bariatric Surgery Does Not Exacerbate and May Be Beneficial for the Microvascular Complications of Type 2 Diabetes
por: Miras, Alexander D., et al.
Publicado: (2012)

Empagliflozin Is Not Renoprotective in Non-Diabetic Rat Models of Chronic Kidney Disease
por: Hojná, Silvie, et al.
Publicado: (2022)

Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial
por: Crowley, Matthew J., et al.
Publicado: (2020)

Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case–control study
por: Miras, Alexander D., et al.
Publicado: (2015)

Renoprotective effects of empagliflozin are linked to activation of the tubuloglomerular feedback mechanism and blunting of the complement system
por: Chen, Xin, et al.
Publicado: (2023)

Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats
por: Trang, Nguyen Ngoc, et al.
Publicado: (2021)

Smart Mom, Rich Mom
por: Palmer, Kimberly
Publicado: (2016)

Liraglutide: another reason to target prediabetes?
por: Murphy, Conor F., et al.
Publicado: (2017)

Clinical Impact of Liraglutide as a Treatment of Obesity
por: Alruwaili, Heshma, et al.
Publicado: (2021)

Urinary Metabolomic Changes Accompanying Albuminuria Remission following Gastric Bypass Surgery for Type 2 Diabetic Kidney Disease
por: Martin, William P., et al.
Publicado: (2022)

Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics
por: Htoo, Phyo T., et al.
Publicado: (2022)

Improvements in diabetic albuminuria and podocyte differentiation following Roux-en-Y gastric bypass surgery
por: Canney, Aoife L, et al.
Publicado: (2019)

Gastric bypass versus best medical treatment for diabetic kidney disease: 5 years follow up of a single-centre open label randomised controlled trial
por: Cohen, Ricardo V., et al.
Publicado: (2022)

Coadministration of Liraglutide With Tacrolimus in Kidney Transplant Recipients: A Case Series
por: Pinelli, Nicole R., et al.
Publicado: (2013)

Cost‐effectiveness of second‐line empagliflozin versus liraglutide for type 2 diabetes in the United States
por: Reifsnider, Odette S., et al.
Publicado: (2022)

Liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5′-monophosphate (AMP)-activated protein kinase signaling pathway
por: Zhu, Xin-Xin, et al.
Publicado: (2021)

Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes
por: Bjornstad, Petter, et al.
Publicado: (2018)

Metal-on-metal (MoM) hip implants and pregnancy: are MoM implants good for mom?—a systematic review
por: Samuel, Linsen T., et al.
Publicado: (2019)

The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease
por: Ehlers, Lars Holger, et al.
Publicado: (2021)

Assessing optimal Roux-en-Y reconstruction technique after total gastrectomy using the Postgastrectomy Syndrome Assessment Scale-45
por: Ikeda, Masami, et al.
Publicado: (2022)

Microvascular capillaroscopic abnormalities and occurrence of antinuclear autoantibodies in patients with sarcoidosis
por: Cattelan, Francesco, et al.
Publicado: (2022)

Quality of life after total vs distal gastrectomy with Roux-en-Y reconstruction: Use of the Postgastrectomy Syndrome Assessment Scale-45
por: Takahashi, Masazumi, et al.
Publicado: (2017)

Renoprotective Effect of Liraglutide Is Mediated via the Inhibition of TGF-Beta 1 in an LLC-PK1 Cell Model of Diabetic Nephropathy
por: Ninčević, Vjera, et al.
Publicado: (2022)

Moms Mean Business
por: Galloway, Lara
Publicado: (2014)

Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes: A randomized controlled study
por: Nakaguchi, Hirotatsu, et al.
Publicado: (2020)

Right hemicolectomy combined with duodenum-jejunum Roux-en-Y anastomosis for hepatic colon carcinoma invading the duodenum: A single-center case series
por: Liu, Pei-Gen, et al.
Publicado: (2023)

New Insights into the Use of Liraglutide—Impact on Cardiovascular Risk and Microvascular Outcomes
por: Wronka, Magdalena, et al.
Publicado: (2023)

Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission
por: Arora, Tulika, et al.
Publicado: (2015)

Dear Mom : thank you for being mine
por: Matthews, Scott
Publicado: (1993)

Empagliflozin and Protecting Microvascular Support of Heart Mechanics: SGLT2 Inhibition or More?
por: Mantsounga, Chris Sorel, et al.
Publicado: (2019)

Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin
por: Juni, Rio P., et al.
Publicado: (2019)

Changes in B-Type Natriuretic Peptide and BMI Following Roux-en-Y Gastric Bypass Surgery
por: Marney, Annis M., et al.
Publicado: (2014)

Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma
por: Chen, Yi-Di, et al.
Publicado: (2022)

Embryos need Mom's nucleolus
por: Robinson, Richard
Publicado: (2008)

It's cold, mom! It's cyclic GMP
por: Kuhn, Michaela
Publicado: (2015)

Dr Mom’s Added Burden
por: Hardy, Seth M., et al.
Publicado: (2021)

Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies
por: de Mesquita, Fernanda Cristina, et al.
Publicado: (2017)

The renoprotective effect of esaxerenone independent of blood pressure lowering: a post hoc mediation analysis of the ESAX-DN trial
por: Okuda, Yasuyuki, et al.
Publicado: (2022)

Effects of liraglutide on extraglycemic inflammatory markers and renal hemodynamic parameters in diabetic kidney disease (DKD)
por: Song, Wenjuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p0ou8g1pnr016i2138hjaktn17